 |
|
|
Evan Jones, chairman and CEO of Digene, will deliver the first lecture of the Fall 2006 semester.
Lecture Date & Time:
November 16, 2006 , 5 p.m.
Reception precedes lecture at 4:30 p.m. |
| |
Abstract
Digene Corporation Chairman and CEO Evan Jones will discuss how Digene emerged from the University of Maryland incubator program to become a regional and national success story in the rapidly growing molecular diagnostics industry. Jones will talk about how he and his team developed and executed a winning plan. He will provide insights into key elements of Digene's success with an emphasis on technology development in the life sciences industry, financing and building a successful business, developing and defending intellectual property portfolios, the FDA approval process, leading a winning team, and operating on a global basis. He will discuss the outlook for the molecular diagnostics industry and how progress in genomics is driving the emerging practice of personalized medicine.
Digene is a world leader in the diagnostics industry with revenues approaching $200 million annually, profitable operations and market capitalization of approximately $1 billion.
Biography
Evan Jones joined Digene in July 1990 as CEO. He was elected to serve on the Board of Directors in July 1990 and became chairman of the Board in September 1995. He served as president of Digene from July 1990 to June 1999. From 1988 to September 1990, Jones was president of Neomorphics, Inc. Between 1987 and 1990, he was first an associate and then a partner with the CW Group, a healthcare venture capital firm. From 1983 to 1987, Jones was employed by Perkin–Elmer Corporation. Jones is a member of the Board of Directors of the Children's Research Institute at the Children's National Medical Center. In June 2004, Jones became chairman of the Board of the Campaign for Public Health, an independent, not–for–profit organization dedicated to conducting direct lobbying of the executive and legislative branches of the U.S. government in support of the aggressive growth of the annual budget of the Centers for Disease Control and Prevention. Jones received a B.A. in biochemistry from the University of Colorado and an M.B.A. from The Wharton School at the University of Pennsylvania.
|
|
|
Nov. 16 , 2006
5 p.m.
1110 Kim Building
|
